KIND

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 29, 2024 in Nextdoor Holdings Lawsuit – KIND

Retrieved on: 
Wednesday, April 3, 2024
NEXT, COVID-19, Fraud, KIND, Security (finance)

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II (NYSE: KIND).

Key Points: 
  • NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II (NYSE: KIND).
  • Shareholders who purchased shares of KIND during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
  • DEADLINE: April 29, 2024 – Shareholders should not delay in registering for this class action.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

Contact The Gross Law Firm by April 29, 2024 Deadline to Join Class Action Against Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II (KIND)

Retrieved on: 
Wednesday, March 27, 2024
NEXT, COVID-19, Fraud, KIND, Security (finance)

NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II (NYSE: KIND).

Key Points: 
  • NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II (NYSE: KIND).
  • Shareholders who purchased shares of KIND during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
  • DEADLINE: April 29, 2024 Shareholders should not delay in registering for this class action.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

The Gross Law Firm Reminds Nextdoor Holdings Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 29, 2024 – KIND

Retrieved on: 
Wednesday, March 20, 2024
NEXT, COVID-19, Fraud, KIND, Security (finance)

NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II.

Key Points: 
  • NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II.
  • Shareholders who purchased shares of KIND during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
  • DEADLINE: April 29, 2024 Shareholders should not delay in registering for this class action.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before April 29, 2024 to Discuss Your Rights – KIND

Retrieved on: 
Tuesday, March 12, 2024
NEXT, COVID-19, Fraud, KIND, Security (finance)

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II.

Key Points: 
  • NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II.
  • Shareholders who purchased shares of KIND during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
  • DEADLINE: April 29, 2024 Shareholders should not delay in registering for this class action.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

Catalina Crunch® Appoints Three New Key Members To Its Growing Leadership Team

Retrieved on: 
Monday, March 4, 2024
Dark, Peanut, Senior, Danone North America, NBA, SVP, Record, Morningstar Farms, Nature, Eggo, Snack, Starbucks, KIND, National accounts, AJ, Partnership

INDIANAPOLIS, March 4, 2024 /PRNewswire/ -- Catalina Crunch®, the pioneering brand in healthier snacks, is excited to unveil the latest additions to its leadership team. The company proudly welcomes Lauri Luker as the Chief Operating Officer, Jim Duddleston as Senior Vice President of National Accounts and West, and Kristy Vigil as Senior Vice President of Natural Channel and East. In their strategic roles, Lauri, Jim, and Kristy will be instrumental in steering Catalina Crunch® into its next phase of robust growth, strategically expanding the brand's retail presence. This significant announcement not only underscores the brand's dedication to meeting the soaring demand for its products but also highlights Catalina Crunch®'s ongoing commitment to fortifying and expanding its executive team.

Key Points: 
  • INDIANAPOLIS, March 4, 2024 /PRNewswire/ -- Catalina Crunch ®, the pioneering brand in healthier snacks, is excited to unveil the latest additions to its leadership team.
  • "We are thrilled to welcome Lauri, Jim, and Kristy to the Catalina Crunch® family.
  • The trio of Lauri Luker, Jim Duddleston, and Kristy Vigil brings a wealth of experience and industry acumen to Catalina Crunch®.
  • For more information on Catalina Crunch® visit us.catalinacrunch.com and follow on Instagram ( @CatalinaCrunch ), Facebook ( @CatalinaCrunch ) and TikTok ( @CatalinaCrunch ).

BAL Promotes John Hamill to Partner at its New York Office

Retrieved on: 
Wednesday, January 24, 2024
KIND, Learning, Volunteering, Political science, Law, BAL, Angelina Jolie, AILA, Columbia University, American Immigration Lawyers Association, Lead, Thomson Reuters, Nursing

DALLAS and NEW YORK, Jan. 24, 2024 /PRNewswire/ -- BAL, the award-winning innovative corporate immigration law firm, announced today the promotion of John Hamill to partner. His legal expertise and commitment to making a positive difference in people's lives makes him a strong addition to the firm's esteemed group of partners.

Key Points: 
  • DALLAS and NEW YORK, Jan. 24, 2024 /PRNewswire/ -- BAL , the award-winning innovative corporate immigration law firm, announced today the promotion of John Hamill to partner.
  • As leader of the New York office, John oversees corporate immigration programs for clients in the pharmaceutical, banking, finance and consumer goods industries.
  • John joined BAL in 2018 as an associate in the New York office.
  • "I am humbled to continue leading and learning alongside my colleagues as we guide the immigration process for our clients, their employees and families," said John Hamill, partner at BAL.

KIND and Lana Condor Invite Americans to Quit the New Year's Resolutions that No Longer Serve Them

Retrieved on: 
Friday, January 12, 2024
KIND, Noise, Taste, Food, Unit, Health, Culture, Partnership, New Year's, Pressure, Snack, Confusion, Dietary supplement

NEW YORK, Jan. 12, 2024 /PRNewswire/ -- Today on Quitter's Day, KIND Snacks is announcing Better You by Lana, a one-day-only immersive wellness pop-up based in Los Angeles, California, that flips the script on how to start the New Year, with actress, Lana Condor. By launching on Quitter's Day, the day by which most Americans have quit their New Year's resolutions, KIND and Lana are inviting consumers to shut out the noise and stress that heightens around the New Year and trust their taste buds.

Key Points: 
  • Health and diet-related New Year's resolutions rank among the highest set during the New Year.
  • Through the pop-up experience and partnership with Lana, KIND invites Americans to think differently about the pressures we face when making choices about food and wellness.
  • It's time to ask ourselves how well these resolutions are serving us," said Lana.
  • The first 100 people in line will receive a custom gift from Lana and KIND while supplies last.

Catalina Crunch® Welcomes Doug Behrens as New Chief Executive Officer to Further its Explosive Growth

Retrieved on: 
Thursday, January 11, 2024
Dark, KIND, Food, NBA, Health, Johnson & Johnson, Danone, Snack, Growth

INDIANAPOLIS, Jan. 11, 2024 /PRNewswire/ -- Catalina Crunch®, the pioneering brand in healthier snacks, is thrilled to announce the appointment of Doug Behrens as Chief Executive Officer (CEO). Behrens will be responsible for bringing Catalina Crunch® into its next phase of growth and expanding the brand's retail footprint at a time when the company's demand is at an all-time high. This important announcement builds on Catalina Crunch's recent growth as the company continues to make ongoing investment in hiring the best talent to join the executive team.

Key Points: 
  • This important announcement builds on Catalina Crunch's recent growth as the company continues to make ongoing investment in hiring the best talent to join the executive team.
  • "I am thrilled to welcome Doug Behrens to the Catalina Crunch® team.
  • "I've been very impressed with the explosive growth of Catalina Crunch® and excited to join the team for the next chapter.
  • The better-for-you food and snacking space is incredibly dynamic and Catalina is well positioned to be a disruptive leader," shared Doug Behrens.

Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis

Retrieved on: 
Monday, December 18, 2023
Atopic dermatitis, Notalgia paresthetica, Itch, BID, TCS, MD, Therapy, NRS, Week, KIND, Tablet, Patient, Safety, CKD, Pharmaceutical industry

STAMFORD, Conn., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the outcome from the dose-finding Part A of the KIND 1 study evaluating the efficacy and safety of oral difelikefalin as adjunct therapy to topical corticosteroids (TCS) for moderate-to-severe pruritus in adult patients with atopic dermatitis (AD). Oral difelikefalin as adjunct to TCS did not demonstrate a meaningful clinical benefit compared to TCS alone, resulting in the Company’s decision to discontinue its clinical program in pruritus associated with atopic dermatitis.

Key Points: 
  • Oral difelikefalin as adjunct to TCS did not demonstrate a meaningful clinical benefit compared to TCS alone, resulting in the Company’s decision to discontinue its clinical program in pruritus associated with atopic dermatitis.
  • “We are disappointed with the outcome of this study recognizing that comparing the adjunctive use of oral difelikefalin with TCS to TCS alone represented a high clinical bar based on anticipated real-world commercial use.
  • Oral difelikefalin as adjunct therapy to TCS did not demonstrate a meaningful clinical benefit compared to TCS alone.
  • Oral difelikefalin was generally well tolerated with a safety profile similar to prior trials.

Rubicon Organics Celebrates Double Triumph at 2023 KIND Magazine’s Awards

Retrieved on: 
Wednesday, December 13, 2023
Sale, CFO, Cannabis, Organic, KIND, Interim, Drug

Rubicon Organics awarded two prestigious wins at the annual KIND Awards;

Key Points: 
  • Rubicon Organics awarded two prestigious wins at the annual KIND Awards;
    Awarded Cannabis Company of the Year, considered KIND’s marquee award;
    Secured People’s Choice Best Weed, voted by over 860 retail owners and budtenders nationwide.
  • VANCOUVER, British Columbia, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon”, or the “Company”), a licensed producer focused on cultivating and selling organic certified, premium cannabis, is pleased to announce it has won KIND Magazine’s (“KIND”) Cannabis Company of the Year award and People’s Choice for Best Weed award.
  • Rubicon Organics clinched the esteemed title of Cannabis Company of the Year, regarded as KIND’s premier accolade.
  • Budtenders, acknowledged as pivotal influencers in the industry, singled out Rubicon Organics for delivering best-in-class cannabis products.